SCHEMBL17802415

SCHEMBL17802415

OC(Cc1ccccc1)C(O)c1ccc(Br)cc1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.53
SLC6A4 P31645 2/20 0.53
SLC6A3 Q01959 2/20 0.53
IGF1R P08069 1/20 0.45
CNR2 P34972 2/20 0.45
CYP19A1 P11511 4/20 0.44
HTR2A P28223 1/20 0.44
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43
TRPA1 O75762 1/20 0.42
FPR2 P25090 2/20 0.41
MME P08473 2/20 0.41
ACP3 P15309 1/20 0.41
CNR1 P21554 1/20 0.40
SIGMAR1 Q99720 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11507691 0.86 SLC6A2 (0.50) SLC6A2SLC6A4SLC6A3TRPA1ACP3
SCHEMBL10554772 0.86 SLC6A2 (0.50) SLC6A2SLC6A4SLC6A3TRPA1ACP3
SCHEMBL28620633 0.83 CALM1 (0.46) SLC6A2SLC6A4SLC6A3TRPA1
SCHEMBL3398678 0.82 IGF1R (0.57) SLC6A2SLC6A4SLC6A3IGF1RCNR2
SCHEMBL17802382 0.81 SLC6A4 (0.53) SLC6A2SLC6A4SLC6A3CNR2MEN1
SCHEMBL17802381 0.81 PPARG (0.45) SLC6A4SLC6A3CNR2CYP19A1TRPA1
SCHEMBL11604717 0.78 SLC6A2 (0.59) SLC6A2SLC6A4SLC6A3IGF1RCYP19A1
SCHEMBL5982885 0.76 SLC18A3 (0.53) IGF1RMEN1NPC1RAB9AKMT2A
SCHEMBL28624377 0.75 LTA4H (0.52)
SCHEMBL108646 0.75 TRPA1 (0.58) SLC6A2SLC6A4SLC6A3TRPA1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016088138-A1 DIPHENYLOXIRANES, PROCESS FOR PREPARATION THEREOF, AND ITS USE IN AN ENANTIOSELECTIVE SYNTHESIS OF (+)-SERTRALINE COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-06-09 WO disclosed